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Differential Effects of Nephrotoxic Agents on
Renal Transport and Metabolism by Use
of In Vitro Techniques
byGerald H. Hirsch*
A number of studies by the author and other investigators are reviewed in which the in Vitro
kidney slice technique has been used to evaluate the nephrotoxicity of various compounds. The
kidney slice technique can be used to determine the effect of prior drug treatment of laboratory
animals on renal organic acid (p-aminohippurate) or organic base (N-methylnicotinamide)
transport, onglucose synthesis, and on oxygen consumption by renal coritical slices. The nephro-
toxic agents uranyl nitrate and potassium dichromate exert inhibitorv effects on renal function,
although both agents enhance organic base transport at low doses and potassium dichromate
enhances organic acid transportatmoderate doses.Enhanced PAH transport has been found to be
a sensitive indicator of gentamicin induced nephrotoxicity, while inhibition of other parameters
has been reported. The tissue slice method is less effective in evaluating chronic nephrotoxicity
such as that produced by lead. The inhibitory effect of mercurial diuretics has been shown to be
due to the general depression of metabolic activity by mercury. The kidney slice technique has
been found to be a sensitive indicator in the assessment of halogenated hydrocarbon-induced
nephrotoxicity. Differential effects of compounds on in vitro organic acid and base trasport pro-
vides information about the transport of these compounds as well as about their nephrotoxicity.
Although it is often desirable to perform in vivo tests or other in vitro renal function tests, the
kidney slice technique has proved tobeextremelyuseful in toxicological evaluations.
Introduction
The kidney is of paramount importance in the
excretion of many drugs and chemicals. Inves-
tigation of the possible renal toxicity of such
agents aids in identifying substances hazardous
to health, and also provides information about the
mechanisms involved in renal function. Our work
has had two primary objectives; first, to study
the potential nephrotoxicity of various drugs or
other substances in normalexperimental animals,
and in some cases, in animals in which some
degree of renal failure has been experimentally
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produced; and secondly, to study the properties
and mechanisms involved in the renal transport
systems fororganic acids and organic bases.
One ofthe methods used to study the secretory
mechanisms for organic acids and bases is based
on an in vitro technique developed by Cross and
Taggart (1) utilizing renal cortical slices.
p-Aminohippurate (PAH) is normally used as the
prototype for organic acids, while tetraethylam-
monium (TEA) and N-methylnicotinamide
(NMN) are the two most commonly used organic
bases. Renal cortical slices are prepared from the
excised kidneys after drug treatment of the ani-
mals for varyinglengths oftime. The tissue slices
are incubated for 90 min under 100% 02 in an
isotonic medium containing PAH and 14O-NMN or
"C-TEA. After incubation, the PAH content of
June 1976 89the slices and medium is analyzed colorimetrical-
ly, while the organic base slice and medium con-
tent is determined using a scintillation counter,
and the active uptake of each ofthese compounds
by kidney slices is reported asthe slice to medi-
um, or S/M ratio.
A simplified illustration of our general ap-
proach in such studies is shown in Figure 1. In ad-
dition to measurement of PAH-NMN accumula-
tion, a number of other measurements of renal
function have also been utilized in our laboratory.
Glucose synthesis by renal cortical slices was
determined after incubation under 95% 02-5%
CO2 for 60 min, with results expressed as umole
glucose/g tissue wet weight/hr. Oxygen con-
sumption by tissue slices was measured with a
Warburg apparatus by use of conventional man-
ometric techniques (1). Urines may be collected
during drug treatment.for measurement of vol-
ume, osmolality or urinary enzymes, and blood
samples obtained for determination of BUN,
serum creatinine or serum enzyme levels.
The kidney slice technique has been used for
many in vitro studies of renal function and
metabolism since this system offers several ad-
vantages: most of the cells are intact; prepara-
tion of experimental samples is straightforward
and samples are easy to handle; the incubation
medium can be manipulated to study effects such
as substrate or ion changes; by pooling slices
from several animals or alternatively dividing
slices from a given animal for use in several flasks
one can compare various parameters directly
while minimizing tissue variability; and physio-
logical factors such as tubular obstruction, dehy-
dration, or blood pressure changes are elimi-
nated.
Treat Animals
> Measure BUN, Creatinine
Do Urinalysis
Kill Animals > Collect Blood Serum Enzymes
BUN, Creatinine
\Electrolytes
> WeighKidneys Drug Levels
Histology
Put Kidneys in Cold Saline
Prepare Renal Cortical Slices
4V
Incubate Slices in Krebs-Ringer
I Medium
Incubate Slices in Cross and Taggart Medium
41
Measure QO2
Measure PAH-NMN Uptake
(
Measure Gluconeogenesis
FIGURE 1. Protocol forrenal function tests.
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Dichromate
In the course ofperformingrenal function tests
followingthe adminstration ofvarious nephrotox-
ic agents, we observed that treatment of adult
male rats with uranyl nitrate specifically in-
creased NMN uptake by rat kidney slices, but
had no effect on PAH accumulation (Fig. 2). Rats
were killed 48 hr after a single IP injection of 6
mg/kg uranyl nitrate. Body weight was the same
in control and treated rats, indicating that the in-
creased kidney weight: body weight ratio repre-
sented increased kidney weight. Additional ex-
periments demonstrated a general effect of ura-
nyl nitrate on organic base transport, since both
TEA and NMN accumulation were enhanced in
cortical slices 24 hr after uranyl nitrate treat-
ment (2).
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FIGURE 2. Effect of uranyl nitrate treatment of adult male
rats on uptake ofNMN and PAH byrenal cortical slices, and
on the kidney weight to body weight ratio. Each bar repre-
sents the mean ± S.E. obtained with duplicate determina-
tions from nine animals. The asterisks indicate values
significantly different from their respective controls
(p<0.05). From Hirsch (2) with permission of the Canadian
Journal ofPhysiology and Pharmacology.
Uranyl nitrate is nephrotoxic at 6 mg/kg, and
the toxicity increases as the time after injection
is prolonged. The data shown in Figure 3 demon-
strate that doses of uranyl nitrate as low as 0.5
and 1.0 mg/kg were able specifically to stimulate
NMN uptake by renal cortical slices when meas-
ured 24 and 48 hr after injection. The degree of
nephrotoxicity elicited by uranyl nitrate was not
12r-
0
:8
cr
".4
Cn
0
)
I-
NMN
)IE *
Ii
C 0.1 0.5 1.0
C 0.1 0.5 10
24 hrs. PAH
c 0.1 05
C 0.1 0.5 1.0
FIGURE 3. Effect of uranyl nitrate treatment of adult male
rats on uptake of NMN and PAH by renal cortical slices.
Rats were killed 24 or 48 hr after a single IP injection of
saline (c) or 0.1 0.5, or 1.0 mg/kg uranyl nitrate. Each bar
represents the mean ± S.E. obtained with duplicate deter-
minations from five animals. The asterisks indicate values
significantly different from their respective controls
(p<0.05). From Hirsch (2) with permission of the Canadian
Journal ofPhysiology and Pharmacology.
directly related to the degree of stimulation of
NMN transport, however. At 0.5 mg/kg, some
cellular swelling of the proximal tubular cells
could be seen, with isolated areas of cellular
necrosis (Fig. 4b). When 6 mg/kg uranyl nitrate
was administered, extensive cellular necrosis
was evident (Fig. 4c) although the degree of
NMN stimulation produced at these two doses
was comparable.
It was then of interest to evaluate in greater
detail the effects produced by another nephrotox-
in, potassium dichromate. Although the effect
was similar in general to the uranyl nitrate re-
sponse, dichromate produced some interesting
differences. At 24 hr after a single subcutaneous
injection ofa low dose ofpotassium dichromate (5
mg/kg), the PAH S/M ratio was significantly
increased, while NMN uptake was enhanced in
renal cortical slices after treatment of rats with
25 or 40 mg/kg potassium dichromate (Fig. 5).
1.0
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FIGURE 4. Effect of uranyl nitrate treatment on kidneys from adult male rats: (a) control, (b) 48 hr after 0.5 mg/kg uranyl nitrate,
(c) 48 hr after 6 mg/kg uranyl nitrate. Magnification x80. From Hirsch (2) with permission ofthe Canadian Journal ofPhysiology
and Pharmacology.
Significant increases in the kidney weight: body
weight ratio and tissue water content were ob-
served. The nephrotoxicity of potassium dichro-
mate was shown by the increased tissue water
content and by the significant depression of the
PAH S/M ratio at 25and 40mg/kg.
Only depression of ion uptake was observed 48
hr after potassium dichromate injection (Fig. 6).
The cellular toxicity produced by dichromate at
this time was extensive and severe. No stimula-
tion of NMN accumulation was produced, and at
40 mg/kg both PAH and NMN uptake were sig-
nificantly depressed. It appears that there is a
fine distinction between the nephrotoxic proper-
ty of dichromate and its ability to induce organic
base transport. At 48 hr after injection, renal
necrosis apparently is severe enough to interfere
with the stimulatory action ofdichromate on base
transport. Thus, although both uranyl nitrate and
potassium dichromate produce renal damage, it
appears thatthis effect is not entirely the same as
the effect of these compounds on organic base
transport.
The action of dichromate on renal metabolism
was also investigated by adding potassium di-
chromate in vitro to incubation beakers (3). PAH
uptake by renal cortical slices was increased at a
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FIGURE 5. PAH and NMN accumulation by rat renal cortical
slices, rat kidney weight to body weight ratio and kidney
water content 24 hr after a single SC injection of adult male
rats with potassium dichromate. Each bar represents the
mean ± S.E. ofdeterminations from six toeightanimals. The
asterisks indicate values significantly different from their
respective controls (p<0.05). From Hirsch (3) with permis-
sion of the Journal of Pharmacology and Experimental
Therapeutics.
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FIGURE 6. PAH and NMN accumulation by renal cortical
slices, rat kidney weight to body weight ratio and kidney
water content 48 hr after a single SC injection of adult male
rats with potassium dichromate. Each bar represents the
mean + S.E. ofdeterminations from three rats. The asterisks
indicate values significantly different from their respective
controls (p<0.05). From Hirsch (3) with permission of the
Jojrnal ofPharmacology and Experimental Therapeutics.
concentration of 10-6M potassium dichromate and
was decreased at 10-3M dichromate. QO2 values
showed a progressive decline as dichromate con-
centration increased. In contrast, the NMN S/M
ratio increased as the concentration of dichro-
mate increased, until at 10-4M the value was
significantly greater than control (3). At 10-3M
potassium dichromate, all of the measured pa-
rameters including NMN uptake, were inhibited
to a significant degree. Thus these in vitro obser-
vations with PAH and NMN parallel the results
obtained after treating the rats with dichromate.
At concentrations greater than 10-4M or at doses
greater than 25 mg/kg at 48 hr, the nephrotoxic
effect of dichromate overwhelms its apparent
stimulatory action on base transport.
The effects of potassium dichromate on a
number of other parameters of renal metabolism
have also been determined. BUN levels were sig-
nificantly increased, while glucose synthesis by
renal cortical slices was inhibited when measured
24 hr after injection of 25 or 40 mg/kg potassium
dichromate (3).
In some experiments, the runout or efflux of
14C-NMN or 14C-PAH was studied in slices after
preloading them with NMN or PAH for 90 min
(4). Slices were then transferred through a series
of 12 beakers containing no NMN or PAH and the
data expressed as DPM of NMN or PAH remain-
ing in the slices as a function ofthe runout beaker
number (time). The first-order NMN runout con-
stant for slices from treated animals was sig-
nificantly less than that for control slices (0.022
vs. 0.045, p <0.05). The initial concentration of
NMN was higher in slices from treated rats, and
the rate of runout was significantly less (4). PAH
runout was similar in slices from control rats and
rats injected with 5 mg/kg dichromate, but was
significantly greater than control in slices from
rats given 40 mg/kg dichromate (4). This is con-
sistent with the observation that 40 mg/kg po-
tassium dichromate produced substantial inhibi-
tion of renal slice PAH content (i.e., the PAH
S/M ratio).
Intravenous injection ofrats with NMN results
in higher NMN cortex/serum (C/S) ratios in rats
that had been given 40 mg/kg potassium dichro-
mate 24 hr earlier (Fig. 7). Rats were killed 30
min after the intravenous injection of C14-NMN,
aliquots of serum and kidney cortex were digest-
ed in soluene (Packard Instrument Company),
and radioactivity then determined. In addition to
the higher C/S ratios in the rats, urinary NMN
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FIGURE 7. In vivo accumulation of '4C-NMN (13 ,uCi/kg, IV)
in kidneys of rats treated 24 hr earlier with saline or 40
mg/kg potassium dichromate. Rats were killed 30 min
following the NMN injection, the concentration of '4C-NMN
in the renal cortex and serum then determined and the
results expressed as the cortex/serum (C/S) ratio. Each bar
represents the mean ± S.E. from six rats. The C/S ratio of
the treated animals is significantly greater than that from
control animals (p<0.05). From Hirsch and Pakuts (5) with
permission ofToxicology andApplied Pharmacology.
June 1976 93excretion was substantially less than in control
animals. Stimulation of the NMN C/S ratio in
vivo, and the decreased runout of NMN in vitro,
indicate that the enhanced NMN accumulation oc-
curring after potassium dichromate is related to
enhanced organic base retention in the renal cor-
tical cells. Whether this retention is due to
specific binding of NMN by organic base recep-
tors, or merely binding of NMN to denatured
protein, has not been established. Nevertheless,
it is evident that the in vivo experiment
corroborates in the in vitro observations with
kidney slices.
Although both uranyl nitrate and potassium di'
chromate enhanced NMN accumulation by renal
cortical slices, stimulation of this proximal
tubular transport system does not appear to be
simply a nonspecific response to cellular injury.
Administration of mercuric chloride (2.5 or 5
mg/kg) produced renal damage that was both
time and dose related as measured by histological
and metabolic techniques (3). PAH and NMN
S/M ratios were not enhanced when mercuric
chloride-induced nephrotoxicity was produced,
suggesting that this nephrotoxin may act at dif-
ferent sites in the renal tubular cells than uranyl
nitrate or potassium dichromate. These observa-
tions also indicate that the changes in in vitro up-
take of PAH and NMN produced by other neph-
rotoxins such as uranyl nitrate and potassium
dichromate can serve as sensitive indicators of
nephrotoxicity.
Studieswith Gentamicin
The in vitro slice technique has also been uti-
lized to evaluate the nephrotoxicity of gen-
tamicin, since there have been a number of
clinical reports of gentamicin toxicity (6,7). Gen-
tamicin is an aminoglycoside antibiotic related to
neomycin, kanamycin, and streptomycin. Like
these other antibiotics, gentamicin is ototoxic,
and vestibular damage has been reported, partic-
ularly in patients with impaired renal function
(8). Next to vestibular damage, nephrotoxicity is
the most important side effect of gentamicin.
After parenteral administration, elimination of
gentamicin is primarily via the kidneys by glo-
merular filtration. Some 80-90% of an injected
dose is recovered in the active, unchanged form
in the urine, leading tQ high urinary concentra-
tions (9). In patients with renal failure, prolonged
elevation ofplasma gentamicin levels is observed
due to its decreased clearance (10). The early
signs of nephrotoxicity in patients are elevated
BUN and plasma creatinine levels.
In using the in vitro slice technique to inves-
tigate the possible nephrotoxicity of gentamicin,
Hirsch (11) made the folIowing observations. At
the lowest dose used (15 mg/kg) no significant
changes were observed in the parameters meas-
ured after 3 weeks of treatment. At 40 mg/kg
some indications of renal toxicity were evident:
glucose synthesis and 02 consumption were in-
hibited, and the kidney weight:body weight ratio
was increased. NMN transport, glucose synthe-
sis, and changes in kidney weight appeared to be
most sensitive to gentamicin treatment; these
parameters were also significantly different from
control after 1 or 2 weeks of treatment at 70
mg/kg gentamicin. PAH accumulation and BUN
levels were not changed (11).
Exacerbation of gentamicin nephrotoxicity by
methoxyflurane has been reported by Barr et al.
(12), and Hirsch (11) has also shown that gen-
tamicin toxicity was increased in rats suffering
from glycerol-induced renal failure. Gentamicin
alone (70 mg/kg IM for 8 days) produced changes
only in kidney weight and glucose synthesis while
glycerol (1 ml/100 g of 50% glycerol in saline sc
on days 1 and 8) produced no changes. Adminis-
tration of both compounds, however, caused in-
creased BUN levels and kidney weight, reduced
PAH-NMN transport by kidney slices, and inhib-
ited glucose synthesis. Measurement of genta-
micin in serum confirmed the in vitro slice obser-
vations in that the gentamicin serum concentra-
tions were significantly higher when both gen-
tamicin and glycerol were administered (11).
Thus, the in vitro method accurately dem-
onstrated the changes in toxicity and reflected
the changes in gentamicin serum concentration.
Recently Cohen et al. (13) completed a gen-
tamicin study on Sprague-Dawley rats. They ex-
amined the effects of gentamicin on several
parameters of renal function in an attempt to
identify "the early functional correlates of gen-
tamicin toxicity." BUN and serum creatinine
levels were somewhat elevated after 4 days of
gentamicin treatment at 100 mg/kg, while the
urinary concentratingcapacity wasreduced. Gen-
tamicin nephrotoxicity has been reported (14) to
be associated with structuralchanges inthe prox-
imal tubules. Cohen et al. (13) found that
gentamicin-treated rats secreted PAH at a higher
ratethan control animals. The results observed in
theirin vivo experiments were then confirmed by
in vitro studies in which renal cortical slices of
rats treated with gentamicin (100 mg/kg/day,
im) accumulated PAH to a greater degree than
Environmental Health Perspectives 94the slices from control animals. The PAH S/M
ratio was enhanced to the greatest extent after 4
days of treatment, with incubation time varying
from 60 to 180 min. No discernable effect on or-
ganic base transport was observed (13).
The production of nephrotoxicity implies the
development of impaired renal function, usually
accompanied by histologic changes. The relation-
ship of enhanced PAH transport to the subse-
quent appearance of renal failure and proximal
tubular necrosis is not clear. The same statement
can be made in reference to the enhancement of
NMN accumulation by uranyl nitrate or potas-
sium dichromate (2,3).
The kidney slice technique was also used to il-
lustrate differences in sensitivity to gentamicin
in different strains of rats. In an effort to utilize
doses closer to that used in humans, we began us-
ingthe Fisher 344 strain ofrats in our gentamicin
studies. This rat strain has been reported to be
more sensitive to a number of drugs, including
gentamicin (14). In one series of experiments,
Fisher 344 rats were treated with 10 mg/kg IM
gentamicin twice daily for 15 days (Table 1,
Series 1). BUN levels were not changed, but
kidney weight was increased, and NMN uptake
was significantly reduced, suggesting that some
nephrotoxicity had been produced using this
dosage schedule. PAH accumulation by renal cor-
tical slices from gentamicin treated rats was
significantly enhanced when compared to con-
trols (Table 2, Series 1), supporting the observa-
tions of Cohen et al. (13). In another set of ex-
periments, the treatment duration for genta-
micin was 4 days (twice daily at 10 mg/kg). The
results (Table 1, series 2) suggest that substan-
tial nephrotoxicity was not produced since kid-
ney weight, BUN levels and NMN transport were
not significantly different from control values.
However, the PAH S/M ratio was still sig-
nificantly enhanced after gentamicin treatment.
Since the earlier experiments had demon-
strated that gentamicin produced only moderate
nephrotoxicity when given at 10 mg/kg twice dai-
ly for 2 weeks, the same dose was administered
three times daily for 2 weeks (Table 2, series 3).
Nephrotoxicity was quite evident now, with kid-
ney weight, BUN levels, and serum creatinine
levels all being significantly greater than control
values. As expected, the NMN S/M ratio was re-
duced. The PAH response was different from
that seen earlier, however, since the PAH S/M
ratio now was significantly lower than control.
Thus, in this experiment in which gentamicin in-
duced substantial nephrotoxicity, a reduction in
organic acid transport was now produced. It can
be seen that both NMN and PAH S/M ratios can
serve as useful indicators of the degree of
nephrotoxicity produced by gentamicin.
Histological observations support the slice
studies on PAH and NMN uptake. When genta-
micin was given at 10 mg/kg twice daily for 2
weeks, minimal nephrotoxicity was produced.
When the gentamicin dose was increased to 10
mg/kg three times daily for 2 weeks, obvious tox-
icity was produced (Fig. 8). Proximal tubules
showed varying degrees of cellular swelling
vacuolar degeneration, necrosis and desquama-
tion of epithelial cells. These changes were even
more evident in kidneys from rats given 40
mg/kg twice daily for 8days (Fig. 8).
The above data suggest that the effects of gen-
tamicin on PAH transport can be dissociated
from the appearance ofrenal failure. It is evident
that high doses of gentamicin which produce
marked nephrotoxicity inhibit PAH transport
(and other parameters of renal metabolism also).
This is similar to the effect of potassium
Table 1. Effect ofgentamicin on various parameters ofrenal function in Fischer 344rats.
Series 1, 15daysa Series 2, 4daysb Series 3, 14daysc
Control Gentamicin Control Gentamicin Control Gentamicin
Kidney wt, g/100 g 0.71±0.01 0.93±0.03d 0.69±0.02 0.73±0.03 0.67±0.02 1.01±0.01d
BUN, mg/100 ml 19±3.5 20±1.2 20±0.4 21±1.8 20±1.0 27±2.0d
Serum creatinine,
mg/100 ml - - - - 0.32±0.04 0.73±0.06d
PAH S/M 7.7±0.3 10.8±O.8 10.3±0.4 14.7±1.7 11.1±0.07 5.8±0.4
NMN S/M 5.7±0.1 3.5±0.6d 6.5±0.3 5.2±0.2 6.8±1.0 2.3±0.1d
a Rats weretreated with saline or 10mg/kggentamicin SC twice daily for 15days. Values represent the mean ± S.E. from 4 rats.
bRats were treated with saline or 10 mg/kg gentamicin SC twice daily for 4 days. Values represent the mean ± S.E. from 6 to 8
rats.
' Rats were treated with saline or 10 mg/kg gentamicin SC three times daily for 14 days. Values represent the mean ± S.E. from
4 rats.
d Values significantly different from their respective controls (p<0.05).
June 1976 95FIGURE 8. Effects of gentamicin on kidneys from Fisher 344 adult male rats: (1) 10 mg/kg gentamycin three times daily for 2
weeks; (2) 40 mg/kg gentamycin twice daily for 8days. Magnification x80.
dichromate, where low doses stimulate PAH
while high doses inhibit PAH transport. With
gentamicin, low doses which did not produce
marked nephrotoxicity still enhanced PAH up-
take by renal cortical slices. Thus, the stimula-
tion ofthe PAH S/M ratio by gentamicin appears
to be a sensitive'and specific indicator ofthe renal
cellular damage produced by this drug.
Studies with Heavy Metals
While the tissue slice method is quite effective
in measuring acute renal tubular necrosis, it is
somewhat less effective in assessing chronic tox-
icity, for example, the toxicity produced by lead.
Of course, it must be kept in mind that it is also
much more difficult to demonstrate chronic neph-
rotoxicity using these renal function tests, since
the kidneys adapt to accommodate toxicity that
has been produced.
In one study, Wistar rats were fed 20/ lead
acetate in their diets for 10 or 40 weeks (15). The
kidney weight/body weight ratio was significant-
ly enhanced in treated rats, while gluconeo-
genesis and pyruvate decarboxylation were in-
hibited. However, BUN levels were not changed,
and neither organic acid transport nor organic
base transport was inhibited by lead exposure. In
10 week old rats exposed to 2 or 4% lead acetate
in the diet since birth, the kidney weight/body
weight ratios were enhanced but this was largely
the result of a decrease in body weight (15). Ac-
cumulation of PAH and TEA by kidney cortical
slices was not markedly altered, although glu-
coneogenesis was inhibited. The BUN changes
were not physiologically important.
The histologic changes in the kidneys of rats
receiving lead acetate from birth via the diet or
via the milk of their dams have also been eval-
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duced in the distal segment of the proximal
tubule in kidneys of 30 day old rats maintained on
diets containing 2°h lead acetate. In addition to
vacuolar degeneration, some cellular necrosis oc-
curred when 4% lead acetate was used. The most
pronounced effects were observed when rats
were maintained on diets containing 20/ lead
acetate for the first 10 weeks oflife; in this group,
lead inclusion bodies were observed in addition to
cellular necrosis and sloughing of tubular cells.
Thus, the histological changes, while minimal,
generally correlated with the results obtained us-
ing kidney slices. These studies show that, in this
type of situation, histological studies and some in
vivo function test should be carried out to comple-
mentin vitro observations.
Gieske and Foulkes (16) have utilized the in
vitro slice technique to study the acute effects of
cadmium on proximal tubular function in rabbits.
After treatment with cadmium (a single IV injec-
tion), cortical slices were incubated in the
presence of varying PAH concentrations. The ac-
tive uptake of PAH by cortical slices from
treated rabbits was severely depressed (16). This
marked inhibition of active PAH transport indi-
cated that the depression of PAH clearance and
PAH extraction (observed in parallel in vivo
studies) resulted from the cytotoxic effects of
cadmium rather than simply from changes such
as renal blood flow differences. Thus, the in vitro
approach clarified observations madein vivo.
Another study in which the tissue slice method
was used to establish the effects of a heavy metal
on renal metabolism was done by Hook and
Hirsch (17). In addition to their well-known ef-
fects on the renal transport of inorganic ions, the
mercurial diuretics also have pronounced effects
on other renal functions, including the organic
anion secretory system. Some of the mercurial
diuretics are organic acids and are capable of be-
ing secreted, but there are some exceptions.
Chlormerodrin is not an organic acid and yet it in-
hibits PAH transport, and some mercurial diu-
retics also inhibit glucose transport. Dog and rat
kidney cortical slices were therefore reflects a
general metabolic inhibition rather than a specific
effect of mercurial compounds on anionic trans-
port. The two acidic mercurials used, meralluride
and mercaptomerin, inhibited the accumulation of
the organic base NMN to the same extent as that
ofPAH in both rat and dogslices (17). In addition,
the nonacidic mercurial chlormerodrin also re-
duced both PAH and NMN uptake. The inhibi-
tory potency of all 3 diuretics was approximately
the same (50% inhibition near 5x10-4M).
Since the S/M ratio of PAH and NMN is
measured in a steady state, it was considered
possible that the effect of the mercurials was on
the retention of organic ions rather than directly
on the transport process. Ross and Farah (19)
demonstrated that the rate of PAH accumulation
during very early incubation times can be used to
measure the actual rate of transport (since at
these early time periods the intracellularly ac-
cumulated PAH is not of sufficient concentration
to alter the next flux). Both the organic acid mer-
curial mercaptomerin and the nonacidic chlor-
merodrin decreased the rate of PAH entry into
the rat renal cortical slices (17). In another in
vitro slice study, it was shown that inhibition of
PAH and NMN uptake was not restricted to diu-
retic compounds since mercuric chloride and
methylmercury both inhibit uptake of PAH and
NMN also, with about 50% inhibition at 10-4M
(20). These slice studies thus demonstrated that
the inhibitory effect of organic mercurial com-
pounds on PAH transport is nonspecific, reflect-
ing general depression of metabolic activity by
these compounds.
Studieswith Halogenated Hydrocarbons
Plaa and his associates have conducted a
number of studies to determine if halogenated
hydrocarbon-induced nephrotoxicity could be
demonstrated using the kidney cortical slice
technique. Carbon tetrachloride (CC14),
chloroform (CHCl3), and trichloroethylene (TCE)
were found to be nephrotoxic on kidney slices
from mice (21). In rats, CC14 was most consistent-
ly nephrotoxic at sublethal doses, as indicated by
inhibition of the PAH S/M ratio (21). CHCl3 and
TCE were less active in terms of maximum effect
(or % inhibition), but were more potent in that
they exerted their effects at lower doses (22). In
mice, CHC13 was the most effective inhibitor of
PAH transport. The minimum subcutaneous dose
of CHC13 that was effective in producing
nephrotoxicity in mice was 0.025 ml/kg. Watrous
and Plaa (22) were able to conclude that CHCI3 is
at least 50times as nephrotoxic inthe male mouse
as in the male rat.
Halogenated hydrocarbons thus produce func-
tional impairment of renal tubules, as indicated
by impairment of renal anionic transport. The
kidney slice technique appears to be a more sen-
sitive method for determining nephrotoxicity in
the mouse since inhibition could be detected at
lower doses. In earlier in vivo studies (23), no
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functional impairment of the kidney as indicated
by changes in PSP excretion or glucose reab-
sorption at doses up to 4 ml/kg. Although this
earlier work revealed no evidence that CC14 im-
paired tubular function, there was some histolog-
ical evidence of renal toxicity. Thus, the in vitro
slice studies described correspond more closely
to the histological observations. In vivo tech-
niques such as PSP excretion have a distinct ad-
vantage, however, in that repeated measure-
ments can be made on individualanimals.
Under certain circumstances, Watrous and
Plaa (21) found that the nephrotoxicity of
halogenated hydrocarbons was decreased when
mice were pretreated one or more times with the
same solvent. This is analagous to earlier findings
by Culliford and Hewitt (24) who found that the
histopathological changes produced in the kid-
neys of male mice were reduced by pretreatment
with CCL.or CHCL3.
The results obtained with kidney slices were
further evaluated by Watrous and Plaa (21) in an
attempt to increase understanding of the mech-
anisms by which CC14 and CHC13 exerted their
nephrotoxic effects. While the hepatoxicity of
these solvents may be associated with the forma-
tion offree radicals that initiate the autocatalytic
breakdown of the smooth endoplasmic reticulum,
it was concluded that there was little evidence
that the nephrotoxicity of these agents results
from metabolites rather than the parent com-
pounds. Kidney slices have been reported to be
much less active than liver slices in metabolizing
CHC13 or CC14 (25).
OtherStudies
Hook et al. (26) utilized the in vitro slice tech-
nique to study various factors associated with the
toxicity of the herbicide 2,4,5-trichlorophenox-
yacetic acid (2,4,5-T). 2,4,5-T is more toxic to dogs
than to rats, and Piper et al. (27) demonstrated
that renal excretion of 2,4,5-T was greater in rats
than in dogs. Hook et al. (26) showed that addi-
tion of2,4,5-T tothe incubation medium produced
a dose-related depression of PAH accumulation.
Inhibition of PAH uptake by 2,4,5-T appeared to
be competitive in nature since the estimated max-
imal velocity of PAH uptake into rat kidney cor-
tical slices was not changed. The apparent Km
was changed by 2,4,5-T. Thus, these studies
demonstrated that, as an organic acid, 2,4,5-T
was actively secreted by rat tissue, which would
explain the shorter biological half-life in this
species. Berndt and Koschier (28) have also used
the in vitro slice method to show that the active
renal tubular transport of 2,4,5-T and 2,4-D con-
tributes tothe lowtoxicity ofthese compounds.
Braun and associates have evaluated the renal
toxicity of heme proteins by determing the ef-
fects of these heme proteins on renal tubular
function, using rat kidney slices (29). Depression
oforganic acid and base transport in kidney slices
was the earliest and most consistent proximal
tubular dysfunction observed. Other parameters
measured included oxygen consumption, ammon-
iagenesis, and gluconeogenesis by renal cortical
slices. Among the various physiological functions
studied, only hippurate and TEA transport were
decreased at 4 hr after subcutaneous glycerol in-
jection. On the other hand, at 24 hr, PAH and
TEA transport and 02 consumption in kidney
slices were significantly decreased (27).
In another in vitro study, Preuss et al. (30) in-
vestigated the effects of urinary proteins from
patients with myeloma on renal tubular function.
Urinary proteins from patients with myeloma had
a generalized depressive effect on proximal
tubular function while urinary proteins from
nephrotic patients did not. This was indicated by
the depression of ammoniagenesis and glucone-
ogenesis, as well as the inhibition of hippurate
and TEA uptake seen utilizing serum from mye-
loma patients (30). Preuss et al. also studied (31)
various parameters of renal function, utilizing in
vitro techniques to investigate the possibility
that some clinical and experimental hypertension
is secondary to deranged kidney metabolism.
They observed that there are significant dif-
ferences in PAH transport and oxygen consump-
tion in kidney slices from normotensive and
hypertensive rats.
Conclusion
In conclusion, we have tried to present a
number of studies in which the in vitro kidney
slice technique has been used to evaluate or
measure the nephrotoxicity produced by a num-
ber of different compounds. This technique has
proved to be extremely useful in assessing renal
toxicity. In many cases it is desirable to do con-
comitant histological studies, measure serum en-
zyme, creatinine, or BUN levels, or use variousin
vivo physiological procedures as additional
sources ofdata fortoxicological evaluation. There
are, of course, a number of disadvantages inher-
ent in the slice technique as an in vitro approach,
although we have stressed the advantages of this
Environmental Health Perspectives 98technique. The in vitro approach obviously can-
not completely replace in vivo methods, but it can
be used in many cases to assess renal toxicity, or
in some situations to verify or clarify results ob-
tainedin vivo.
The author wishes to express his thanks to Mr. Alex Bayne
and Mr. Attila Pakuts for their assistance and to Dr. E. Nera
for his preparation andevaluation ofthe histological figures.
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